Search results
Results from the WOW.Com Content Network
Medullary thyroid cancer is a form of thyroid carcinoma which originates from the parafollicular cells (C cells), which produce the hormone calcitonin. [1] Medullary tumors are the third most common of all thyroid cancers and together make up about 3% of all thyroid cancer cases. [2] MTC was first characterized in 1959.
The prognosis of thyroid cancer is related to the type of cancer and the stage at the time of diagnosis. For the most common form of thyroid cancer, papillary, the overall prognosis is excellent with 97%, 95%, and 90% 10, 15 and 20 year overall survival respectively. [57] The 5 year survival of all thyroid cancers, with treatment, is 98%. [10]
[13] [19] The ideal age for surgery is 4 years old or younger, since cancer may metastasize before age 10. [14] Pheochromocytoma - a hormone secreting tumor of the adrenal glands - is also present in 50% of cases. [14] Affected individuals are encouraged to get yearly screenings for thyroid and adrenal cancer. [citation needed]
According to the Cleveland Clinic, papillary thyroid cancer generally spreads slowly and more than 90% of adults go on to live at least 10 to 20 years post-treatment. Treatment
Calcitonin is a 32 amino acid peptide hormone secreted by parafollicular cells (also known as C cells) of the thyroid (or endostyle) in humans and other chordates [5] in the ultimopharyngeal body. [6] It acts to reduce blood calcium (Ca 2+), opposing the effects of parathyroid hormone (PTH). [7]
Elevated calcitonin levels in the blood have been shown to be associated with the rare medullary thyroid cancer. However, the measurement of calcitonin levels as a diagnostic tool is currently controversial due to falsely high or low calcitonin levels in a variety of diseases other than medullary thyroid cancer. [26] [27]
ATC is an uncommon form of thyroid cancer only accounting for 1-2% of cases, but due to its high mortality, is responsible for 20-50% of deaths from thyroid cancer. [2] The median survival time after diagnosis is three to six months. [2] Some studies report that 10% to 15% survive more than 1 year; 3-year and 5-year survival is very rare.
Papillary thyroid cancer (papillary thyroid carcinoma, [1] PTC) is the most common type of thyroid cancer, [2] representing 75 percent to 85 percent of all thyroid cancer cases. [1] It occurs more frequently in women and presents in the 20–55 year age group. It is also the predominant cancer type in children with thyroid cancer, and in ...